FDA Inspection
CorneaGen - BostonCorneaGen - Boston – FDA Inspection, Jun 9, 2023
Record Details
This FDA Inspection record concerns CorneaGen - Boston, with an inspection on June 9, 2023, issued by the New England District Office.
- Company
- CorneaGen - Boston
- Inspection Date
- June 9, 2023
- People
- La-tasha M. Gunter (Issuing Officer)
- Lorayne A. Mcguinness
View Company Profile
ID · 1eb901f6-19b0-405f-8bab-144f6e931eea
Inspection Facts
- Inspection number
- 1207719
- FDA center
- Biologics
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
- 21 CFR 1271.210(d)(1)Receipt documentation elements
- 21 CFR 1271.210(d)(2)Verification elements
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CorneaGen - Boston
6| Date | Classification | Office | Project area |
|---|---|---|---|
| December 20, 2024 | Not classified | New England District Office | Human Cellular, Tissue, and Gene Therapies |
| March 5, 2020 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 12, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 20, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 28, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CorneaGen - Boston
- FDA Inspection 1257221 - 2024-12-20
- FDA Inspection 1121216 - 2020-03-05
- FDA Inspection 1068364 - 2018-09-12
- FDA Inspection 941531 - 2015-08-20
- FDA Inspection 824487 - 2013-03-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.